Clinical Trial Update: Safety and Efficacy Study of Intravitreal Ocriplasmin in Subjects With AMD With Focal Vitreomacular Adhesion [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety and efficacy of intravitreal ocriplasmin in subjects with exudative age-related macular degeneration and focal vitreomacular adh…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Focal Vitreomacular Adhesion
• Neovascular Age-related Macular Degeneration

Drugs mentioned

• Ocriplasmin (Jetrea) (ocriplasmin)

Snippet

Sponsor: ThromboGenics | Conditions: Exudative Age-Related Macular Degeneration, Focal Vitreomacular Adhesion | Phase 2 | Status: COMPLETED | Results posted: 2014-05-05